Barco NV Overview
Barco is a Belgian visualization, networking and collaboration technology company with nine decades of engineering heritage. It sells into three professional end-markets: Entertainment (digital cinema, immersive/live-event projection, image processing and, since May 2026, premium audio via Focal and Naim); Enterprise (ClickShare wireless meeting-room collaboration and Control Rooms visualization and KVM software); and Healthcare (diagnostic, surgical and modality displays plus software). Barco holds leadership positions in laser cinema projection and high-end 3-chip DLP projection. ClickShare is a category-defining wireless BYOD brand with more than 1.35 million meeting rooms installed. Diagnostic displays are a long-standing franchise in radiology and mammography. Revenue was EUR 963.8M in FY2025 at a 13.0% EBITDA margin. Strategy is shifting from one-off hardware sales toward software, services and recurring "as-a-service" models, anchored by HDR by Barco Lightsteering cinema. Stated targets for 2028 are EUR 1.1bn revenue, a 15% EBITDA margin and 15% recurring revenue. A weak 2026 has, however, put that trajectory under scrutiny.
Company self-description
In its press-release boilerplate (FY2025 and 1H26), Barco calls itself a global technology company that leads in visualization, networking and collaboration solutions. It says its technologies advance the healthcare, enterprise and entertainment markets, and it refers to its more than 3,000 employees as "visioneers". The 1H26 release adds an explicit ambition: to become a fully integrated audiovisual solutions provider across professional and consumer markets. That ambition followed the VerVent acquisition.
Independent characterization
Barco is a mid-cap, engineering-led specialty hardware company. Software and services are a growing layer on top of the hardware. Its economic engine is the design and manufacture of high-performance imaging systems: laser projectors, medical-grade displays, video walls, image processors and wireless collaboration devices. These are sold mostly through channel partners (integrators, resellers, distributors, OEMs) and large direct accounts such as cinema exhibitors, hospital groups and utilities.
Three features define its economics:
-
Niche leadership at the high end. Barco tends to dominate premium, specification-driven niches such as DCI laser cinema, 3-DLP immersive projection, mammography and diagnostic displays, and wireless BYOD meeting rooms. It does not compete in volume consumer segments.
-
Cyclicality and lumpiness. Large cinema refresh programmes, theme-park projects, government and utility control rooms, and OEM modality contracts make quarterly revenue uneven. Revenue is structurally skewed to the second half. In FY2025, H2 sales were EUR 509.5M against EUR 454.4M in H1.
-
An ongoing business-model pivot. Barco is moving from capex-style one-time sales to opex-style recurring models: Cinema-as-a-Service (CaaS), HDR by Barco performance-based contracts, Barco CTRL software, QAWeb/ConnectCare healthcare software services and ClickShare software/cloud. Recurring revenue reached 13% of sales in 1H26, against a 15% target by 2028.
Revenue model mix
| Indicator | Value | Source |
|---|---|---|
| Recurring revenue share of sales | 13% (1H26), up 4% YoY | 1H26 results / earnings call summary |
| Target recurring revenue share | 15% by 2028 | CMD Oct 2025; FY25 PR |
| CaaS / HDR by Barco recurring contracts signed (total contract value) | EUR 89M (FY2025) | FY25 PR |
| Software share of Control Rooms sales | >20% (FY23) → >30% (FY24) → >35% (1H25) | FY24 PR; 1H25 call deck |
| ClickShare volume mix (FY24) | ~60% Conference, ~10% Bar, ~30% Present | FY24 PR |
Barco does not publish a full product/service/subscription/licensing split. Disclosed or derivable indicators:
Characterization: Roughly 85–87% of revenue is still product (hardware with embedded software). The remainder is service, maintenance, software licences and as-a-service contracts. Licensing to third parties is immaterial; IP is used mainly defensively, as in the ClickShare patent enforcement.
Value-chain position
Barco is an OEM and system designer with significant in-house manufacturing:
-
Kortrijk, Belgium: main plant, with a new automated warehouse.
-
Wuxi, China: Entertainment factory opened in May 2024.
-
Suzhou, China: Healthcare hub; modality business now fully run from here.
-
VerVent's French production (Saint-Étienne area) for Focal speakers.
Barco buys DLP chips (Texas Instruments), LCD panels, laser modules, LED panels (via partners under the "LED Alliance") and electronic components. Sales run through integrators, distributors and resellers, plus direct sales to cinema circuits, OEMs (modality displays sold to imaging-equipment makers) and large enterprises.
Customer types and end-markets
| Division | Customers | End-markets |
|---|---|---|
| Entertainment | Cinema exhibitors (e.g., Vue, Regal, Kinopolis, Cineplex Germany, TDI in India), post-production studios, rental & staging companies, theme parks, museums/experiential venues, simulation integrators, high-end residential and consumer audio buyers | Cinema, live events, themed entertainment, simulation & training, home cinema, consumer/automotive/yachting audio |
| Enterprise | Corporate IT and facilities departments (via AV/IT channel), utilities, energy, transport, public safety, government, process industries | Meeting rooms/workplace; mission-critical control rooms |
| Healthcare | Hospitals, radiology groups, breast-imaging centres, pathology labs, surgical suites, medical-imaging OEMs | Diagnostic imaging, surgery/digital OR, modality |
Strategy
Stated strategy (themes, paraphrased from FY25 PR, CMD 2025 and 1H26 PR)
"Eye on Tomorrow" (CMD, Oct 2025): Shape the future of visualization, connectivity and intelligent workflows, using new products, software-driven growth and operational efficiency.
"Go deep, go broad" (KBC summary of CMD): Go deeper into software and AI on top of hardware leadership; go broader into mid-segment markets (I600, NexxisCube, ClickShare Hub).
Capex-to-opex shift: Move from one-time hardware sales to recurring revenue (CaaS, HDR by Barco, Barco CTRL, QAWeb/ConnectCare).
Integrated AV (2026): Become a fully integrated audiovisual solutions provider; CEO described it as going "all-in" on Entertainment with the VerVent deal.
Portfolio focus (1H26): Sharpen focus on businesses with structural growth drivers and clear differentiation; protect leading market positions and margins; accelerate the software and AI roadmap.
Strategic initiatives — last 24 months
| Initiative | Date | Description / target |
|---|---|---|
| HDR by Barco commercial roll-out | 2025–26 | 50+ installs FY25; pipeline ~100; Vue (61+ EPIC screens by 2027), Regal RPX (20 US screens), Cineplex Germany, TDI (30 screens in India/Sri Lanka/Bangladesh by 2027); 45+ titles in 2026 |
| Cinema-as-a-Service expansion | Ongoing | EUR 89M TCV signed FY25 (with HDR) |
| New Immersive platforms (QDX, I600, F-400, Encore 3) | 2H24–2025 | Share gains in 1-DLP and 3-DLP; theme parks |
| ClickShare Hub / MDEP room systems | Dec 2025 → 2026 | Entry into proprietary room systems (Microsoft Teams Rooms); new bundles and BYOD-MTR switch |
| Barco CTRL software pivot | Since mid-2023 | Software >35% of CR sales (1H25); focus on energy & utilities, process control, infrastructure |
| LED Alliance + Infinipix | 2,025 | Partner LED panels with Barco processing |
| Healthcare AI / surgical compute | Apr 2026 | Unified surgical AI platform (NVIDIA GTC); Brilliant Assistant; digital pathology AI workflows |
| Healthcare reorganization | 2025–Jul 2026 | Surgical + Diagnostic Imaging under common leadership; Modality to Suzhou; all Healthcare under John Zhao |
| VerVent acquisition (Focal/Naim) | Mar–Apr 2026 | ~EUR 135M EV; new Consumer Experience BU; synergy targets not quantified |
| Manufacturing footprint | 2024–26 | Wuxi plant; Changping closed; Kortrijk automated warehouse; mirror manufacturing for tariff flexibility |
| Cost programme | 2024–2026 | FY24 indirect costs −4%; FY25 opex −5%+; 2026 leaner management structure (savings not quantified) |
| Capital returns | 2025–26 | EUR 60M + EUR 30M buybacks; 5.575M shares (~6%) cancelled May 2026 |
| Sustainability ("Sustainable Impact Journey") | Since 2024 | 85% eco-labelled revenue by 2028; −25% absolute carbon emissions by 2030 vs 2024; employee engagement >75%; NPS >50 |
Management targets and guidance
| Horizon | Target / guidance | Status |
|---|---|---|
| FY2026 (original, Feb 2026) | Topline and EBITDA-margin growth vs FY25 excluding FX; H2-weighted | Withdrawn in effect (Apr 2026 warning) |
| FY2026 (current, Jul 2026) | Sales above FY25 (incl. VerVent); EBITDA margin 11–12% (like-for-like basis) | Current; 3Q26 update due 20 Oct 2026 |
| 2028 (CMD Oct 2025; reaffirmed Feb, Apr and Jul 2026 incl. VerVent) | ~EUR 1.1bn revenue; 15% EBITDA margin; 15% recurring revenue | Maintained |
| 2028 ESG | 85% eco-labelled revenue | 76% in FY25 |
| 2030 ESG | −25% absolute carbon emissions vs 2024 | In progress |
Products & Services
Specifications are as described in Barco materials; pricing is not publicly disclosed unless noted. Launch years are given where disclosed.
Entertainment — Cinema
| Product / offering | Description & capabilities | Target customer | Launch / latest | Pricing model |
|---|---|---|---|---|
| HDR by Barco (Lightsteering) | Premium large-format (PLF) cinema system. Patented Lightsteering redistributes laser light to deliver high contrast, deep blacks, bright highlights and wide colour gamut. 50+ projectors installed in FY25; pipeline of about 100 more; 45+ titles expected in 2026 | Premium exhibitors (Vue "EPIC", Regal RPX, Cineplex "ULTIMATE", Alamo, TDI India), post-production studios | Pilot Oct 2024; commercial 2025 | Upfront capex plus recurring licences, maintenance and service; some performance-based models |
| HDR by Barco post-production / colour grading | Colour-grading and mastering solutions to create HDR content | Post-production studios | 2,025 | Software/recurring |
| Series 4 laser cinema projectors | All-laser DCI projectors across screen sizes; core of lamp-to-laser renewal | Mainstream exhibitors (e.g., Vue 1,000+ units by 2029; Kinopolis 100% of mainstream screens) | Series 4 current generation | Capex or CaaS |
| Laser light upgrade | Converts installed lamp projectors to laser | Exhibitors with legacy fleets | Ongoing | Capex/service |
| Cinema-as-a-Service (CaaS) | Projection delivered as a service (ex-Cinionic model): equipment, maintenance and monitoring | Exhibitors preferring opex | Integrated into Barco 2024 | Subscription/recurring; EUR 89M TCV signed in FY25 (with HDR) |
| mFusion ICMP-XS media server | Media server with integrated audio processing | Exhibitors | Showcased CineEurope 2026 | Product |
| Barco Smart Amplifier | Cinema audio amplification | Exhibitors | Showcased CineEurope 2026 | Product |
| myCinema | Cloud portal for projector fleet management | Exhibitor technical teams | 2,026 | Software/service |
| Residential projectors | High-end home-cinema projection | Luxury residential integrators | Ongoing | Product |
Entertainment — Immersive Experience
| Product | Description | Target | Launch |
|---|---|---|---|
| QDX | High-end 3-chip DLP laser projector platform for large immersive venues | Rental & staging, flagship venues | 2H24 |
| I600 | Mid-segment 1-chip DLP laser projector; gaining share in theme parks | Theme parks, museums, fixed installs | 2H24 |
| F-400 | Simulation projector | Flight/defence/training simulator integrators | 2H24 |
| G-series (e.g., G50) | Compact laser installation projectors | Corporate, education, venues | Current |
| Rental projectors | High-brightness touring projectors | Rental & staging | Current |
| Encore 3 | Next-generation image processing/presentation switching for high-end live events | Live productions, broadcast | Pre-orders 4Q24; shipping Jun 2025 |
| Event Master series | Image processing/screen management | Live events | Current |
| SwiftAgent (all-in-one switchers) | Integrated presentation switchers | Corporate/venue AV | Current |
Entertainment — Consumer Experience (VerVent, from May 2026)
| Brand / line | Description | Target |
|---|---|---|
| Focal (France, founded 1979) | Floorstanding and bookshelf loudspeakers, custom-integration and immersive speakers, studio monitors, headphones, automotive and yachting OEM audio. Designed and made largely in-house in France | Audiophiles, home cinema, pro studios, car OEMs |
| Naim (UK, roots 1973) | Two-channel hi-fi electronics, amplifiers, streaming systems, music servers | Audiophile and premium streaming buyers |
| "Focal Powered by Naim" stores | Dozens of branded concept stores globally | Premium retail |
Group facts: VerVent revenue about EUR 110M per year, about 600 staff, HQ Saint-Étienne. Barco cites an addressable premium-audio segment above EUR 3bn. In 1H26, headphones and automotive audio performed strongly, while integrated and passive solutions were weaker.
Enterprise — Meeting Experience (ClickShare)
| Product | Description | Target | Launch |
|---|---|---|---|
| ClickShare Present (e.g., C-5, C-10) | Wireless presentation via button or app | Huddle and meeting rooms | Brand since 2012 |
| ClickShare Conference (CX-20, CX-30, CX-50, CX-50 Gen 2) | Wireless conferencing: users run their own VC platform on a laptop while using room AV (BYOD/BYOM) | Corporate meeting rooms | Current |
| ClickShare Bar (Core/Pro) | All-in-one video bar with wireless conferencing | Small/medium rooms | ~10% of FY24 volume |
| ClickShare Hub | Modular video-conferencing room system on Microsoft MDEP; Microsoft Teams Rooms-certified; Barco's first product in proprietary room systems | Enterprises standardizing on Teams Rooms | Certified/shipping Dec 2025 |
| BYOD-MTR switch; wireless BYOD for Hub | Lets one room toggle between BYOD and native MTR | Hybrid-work IT | 2,026 |
| Partner video bar (Huddly C1) | Co-developed with Huddly and Lenovo | Room systems | Sep 2025 |
Installed base: more than 1.35 million meeting rooms (FY24 PR). IP: protected by more than 110 patents.
Enterprise — Control Rooms
| Product | Description | Target |
|---|---|---|
| Barco CTRL | All-in-one operator workspace and KVM-over-IP platform; security by design (supports NERC-CIP compliance); collaborative control; software share rising | Energy & utilities (T&D), process control, transport, public safety, government |
| TransForm N | Legacy networked visualization management system | Installed base |
| LCD video walls (e.g., UniSee II) | Bezel-minimized LCD walls | Control rooms |
| Rear-projection video walls | Barco says it is now the sole remaining supplier of rear-projection cubes, driving replacement demand | Utilities and transport with legacy cube walls |
| LED video walls (e.g., NT0.9-I) + Infinipix | LED panels from partners combined with Barco's Infinipix image processing ("LED Alliance") | Control rooms, corporate lobbies |
| Controllers | Video wall controllers | Control rooms |
Healthcare
| Product | Description | Target | Launch |
|---|---|---|---|
| Radiology displays (Coronis/Nio families) | Diagnostic grayscale and colour displays; calibrated for DICOM compliance | Radiology departments | Ongoing |
| 8MP home-reading portfolio | Diagnostic displays for remote reading, managed via QAWeb | Teleradiology | Mid-2024 |
| OneLook | Flagship mammography display with collaboration software | Breast-imaging centres | Oct 2024 |
| Digital pathology displays | Colour-critical displays for whole-slide imaging; AI workflow pipeline | Pathology labs | Growing double-digit |
| Clinical review & dental displays | Review-grade displays | Clinicians, dental | Ongoing |
| 3D medical displays | Stereoscopic visualization for precision workflows | Surgical/clinical | 2,025 |
| QAWeb | Cloud quality-assurance/calibration management | Hospital IT/physics | Ongoing |
| ConnectCare | Software-enabled service | Hospitals | 2,025 |
| SlideRightQA | QA tooling for digital pathology | Pathology | 2,025 |
| Nexxis | IP-based surgical video networking/integration platform | Operating rooms | Ongoing |
| NexxisCube | Mid-segment surgical networking system | Mid-tier ORs | 2,025 |
| Surgical displays | Surgical-grade monitors (incl. 4K/large format) | ORs | Ongoing |
| Brilliant Assistant | AI-powered, voice-controlled surgical display for hands-free interaction | ORs | Roadmap (2025–26) |
| Unified surgical AI platform | Real-time compute platform unveiled at NVIDIA GTC | Surgical AI developers/hospitals | Apr 2026 |
| Modality displays (OEM) | Displays embedded in imaging equipment from OEM partners | Imaging OEMs | Run from Suzhou |
Services
Enterprise, Entertainment and Healthcare service programmes cover maintenance, extended warranties, remote monitoring and training. Revenue is not separately disclosed.
Financial Narrative
Income statement
Notes:
-
FY21 and FY22 gross profit are the sum of divisional gross profit (derived).
-
FY21 revenue growth versus FY20 is approximate; FY20 is not shown here.
-
Dividends are shown for the fiscal year they relate to (FY21 EUR 0.40 per the 2022 optional-dividend release; FY22 EUR 0.44 per the FY22 deck; FY23–FY25 per results releases).
Supplementary income-statement items (incomplete series, not chart-ready):
The derived pre-tax figure ignores minority interests and equity-accounted results (e.g., the CFG Barco JV), so it differs slightly from the 18% effective tax rate implied.
Revenue CAGR (derived):
-
FY2021–FY2025: +4.6% per year (804.3 → 963.8).
-
FY2022–FY2025: −3.1% per year (1,058.3 → 963.8).
-
Barco's 2028 target of EUR 1.1bn implies about 4.5% CAGR from FY25 (Test-Achats calculation), now including VerVent.
Commentary — income statement. The five-year arc has three phases:
-
Post-COVID rebound (FY21→FY22). Sales rose 32% and EBITDA more than doubled once supply chains eased.
-
Plateau and retreat (FY23→FY24). Sales fell 10% in FY24. Drivers were channel inventory resets in ClickShare and Healthcare, the after-effects of the 2023 Hollywood strikes, and weak EMEA. Cost discipline (indirect costs −4%) and the sale-leaseback gain limited the margin damage to 0.8 pts.
-
Fragile recovery, then relapse (FY25→1H26). FY25 grew 2% (+4% at constant currency) with EBITDA margin up to 13.0%, despite about EUR 8M of FX and EUR 7M of tariff headwinds cited on the earnings call. 1H26 then saw EBITDA collapse to EUR 26.1M (6.2% margin) on lower sales, an adverse mix (weak ClickShare and surgical) and a EUR 20.7M currency effect.
Gross margin peaked at 41.8% in FY23. Since then, a richer software mix has been offset by product-mix shifts toward lower-margin cinema volume deals and by tariffs. Net income has tracked EBITDA, with a stable 18% tax rate and positive net interest income.
Balance sheet
Sources: working-capital lines from Barco FY24/FY25 PRs. Total assets, equity and cash are from aggregators (Fintel/TipRanks).
Supplementary balance-sheet items (incomplete series):
Discrepancies:
-
Stockopedia reports lower equity (694 / 759 / 795 / 795 for FY21–FY24) and slightly different cash balances (355 / 310 / 295 / 363). The difference likely reflects minority-interest treatment and cash definitions.
-
The short/long-term debt split is not disclosed in the sources reviewed. Barco has no bonds; its gross debt consists mainly of lease liabilities, which increased after the 2024 sale-leaseback.
Commentary — balance sheet. Barco has historically run a fortress balance sheet, with net cash of EUR 240–265M across FY22–FY24, which funded scrip-free dividends and buybacks. In FY25, net cash fell by EUR 73M after EUR 44.2M of dividends and EUR 79.1M of buybacks exceeded EUR 57.2M of FCF. By mid-2026 the company had swung to a net debt of EUR 32.6M. Drivers were the EUR 135M VerVent acquisition (financed from own funds), negative 1H FCF of EUR −36.7M, the FY25 dividend and the buyback tail.
Leverage remains modest (well under 0.5x EBITDA). However, the capacity to keep returning cash at FY25 levels while investing in growth is clearly reduced. Equity fell by about EUR 80M in FY25, reflecting buybacks and negative currency translation (EUR −31.8M OCI attributable in FY25 per the IR2025 financial statements).
Cash flow
Shareholder distributions:
1H26 FCF was EUR −36.7M, driven by inventory build: advance component purchasing ahead of price increases plus unsold finished goods. Capex in 1H26 was EUR 15.4M.
Commentary — cash flow. Cash conversion is volatile and driven by working capital. FY22 FCF was nearly wiped out by a EUR 70M inventory build during supply-chain stress. FY24 benefited from a EUR 60M working-capital release plus EUR 12.5M of sale-leaseback proceeds. FY25's EUR 57M is closer to underlying run-rate (about 6% of sales).
Capex stepped up in FY23 (EUR 54.4M) for the Chinese factories and has since normalized to about 4% of sales. That spend increasingly funds CaaS assets, which convert capex into recurring revenue, and Kortrijk automation. At the October 2025 CMD, management expected EUR 200–250M of FCF over three years (KBC note). After 1H26, that looks stretched unless 2H26 working capital unwinds sharply.
Ratios
Commentary — ratios. Returns are mediocre for a technology leader. ROE has stayed around 8–10% and ROCE at 14%, held back by a large cash pile (until 2025) and working-capital intensity. The cash conversion cycle of 160–190 days is long and reflects 2x inventory turns. Improvement after FY23 came from longer payables, not faster inventory. The 2028 targets (15% EBITDA margin, 15% recurring revenue) would lift ROCE only if working-capital intensity also falls. The 1H26 inventory build moved in the opposite direction.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Division Overview
| Division | Business units | What they contain |
|---|---|---|
Entertainment | Cinema; Immersive Experience; Consumer Experience (new from 1 May 2026, i.e. VerVent) | Cinema laser projectors, HDR by Barco, media servers, CaaS; high-brightness projectors for live events, theme parks, simulation; image processing (Event Master, Encore 3); Focal/Naim audio |
Enterprise | Meeting Experience; Control Rooms | ClickShare portfolio; Barco CTRL software, video walls (LCD, rear-projection, LED with Infinipix), controllers |
Healthcare | Diagnostic Imaging; Surgical & Modality (being integrated) | Radiology, mammography, pathology, clinical review and home-reading displays plus QAWeb; Nexxis surgical networking, surgical displays; OEM modality displays |
Division sales (EUR Mn)
| Division sales (EUR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Healthcare sales (EUR Mn) | 261.5 | 341.7 | 285.9 | 273.2 | 262.0 |
Enterprise sales (EUR Mn) | 233.1 | 317.2 | 303.8 | 254.1 | 235.1 |
Entertainment sales (EUR Mn) | 309.7 | 399.3 | 460.5 | 419.3 | 466.8 |
Group sales (EUR Mn) | 804.3 | 1,058.3 | 1,050.1 | 946.6 | 963.8 |
Division EBITDA (EUR Mn)
| Division EBITDA (EUR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Healthcare EBITDA (EUR Mn) | 22.4 | 38.4 | 27.8 | 34.2 | 26.5 |
Enterprise EBITDA (EUR Mn) | 14.6 | 60.7 | 56.9 | 32.4 | 29.6 |
Entertainment EBITDA (EUR Mn) | 21.5 | 27.5 | 57.7 | 54.1 | 68.9 |
Group EBITDA (EUR Mn) | 58.5 | 126.5 | 142.5 | 120.8 | 125.1 |
Division margin (%)
| Division margin (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Healthcare gross margin (%) | 33.3 | 34.1 | 36.0 | 38.6 | 37.6 |
Enterprise gross margin (%) | 46.6 | 54.3 | 53.6 | 50.0 | 52.0 |
Entertainment gross margin (%) | 29.6 | 31.1 | 37.5 | 36.4 | 35.4 |
Healthcare EBITDA margin (%) | 8.6 | 11.2 | 9.7 | 12.5 | 10.1 |
Enterprise EBITDA margin (%) | 6.3 | 19.1 | 18.7 | 12.8 | 12.6 |
Entertainment EBITDA margin (%) | 6.9 | 6.9 | 12.5 | 12.9 | 14.8 |
Revenue by Segment
| Division orders (EUR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Healthcare orders (EUR Mn) | 329.8 | 319.7 | 254.9 | 271.5 | 253.9 |
Enterprise orders (EUR Mn) | 262.4 | 281.3 | 304.9 | 250.6 | 229.5 |
Entertainment orders (EUR Mn) | 386.6 | 457.4 | 501.8 | 468.5 | 461.9 |
Group orders (EUR Mn) | 978.8 | 1,058.4 | 1,061.6 | 990.6 | 945.4 |
Year-end order book (EUR Mn) | 487.0 | 496.5 | 494.8 | 563.7 | 492.8 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Margins & Growth (%) and Revenue by Segment (%)
| Metric (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Healthcare sales YoY growth (%) | 30.7 | -16.3 | -4.4 | -4.1 |
Enterprise sales YoY growth (%) | 36.1 | -4.2 | -16.4 | -7.5 |
Entertainment sales YoY growth (%) | 28.9 | 15.3 | -8.9 | 11.3 |
Healthcare share of group sales (%) | 32.3 | 27.2 | 28.9 | 27.2 |
Enterprise share of group sales (%) | 30.0 | 28.9 | 26.8 | 24.4 |
Entertainment share of group sales (%) | 37.7 | 43.9 | 44.3 | 48.4 |
BU sales (EUR Mn, derived)
| BU sales (EUR Mn, derived) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Cinema (EUR Mn) | 248.7 | 247.4 | 270.7 |
Immersive Experience (EUR Mn) | 211.8 | 171.9 | 196.1 |
Meeting Experience (EUR Mn) | 182.3 | 134.7 | 129.3 |
Control Rooms (EUR Mn) | 121.5 | 119.4 | 105.8 |
Revenue by Segment (1H2025–1H2026)
| 1H metric (EUR Mn) | 1H2025 | 1H2026 |
|---|---|---|
Entertainment sales (EUR Mn, derived) | 209.2 | 199.5 |
Enterprise sales (EUR Mn) | 107.5 | 97.9 |
Healthcare sales (EUR Mn) | 137.6 | 120.7 |
Group sales (EUR Mn) | 454.4 | 418.1 |
Entertainment orders (EUR Mn, derived) | 236.4 | 243.5 |
Enterprise orders (EUR Mn, derived) | 109.6 | 115.1 |
Healthcare orders (EUR Mn, derived) | 141.8 | 109.2 |
Group orders (EUR Mn) | 487.5 | 467.8 |
Group EBITDA (EUR Mn) | 48.0 | 26.1 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (EUR Mn) | 804.3 | 1,058.3 | 1,050.1 | 946.6 | 963.8 |
Revenue YoY growth (%) | 5.0 | 31.6 | -0.8 | -9.9 | 1.8 |
Gross profit (EUR Mn) | 287.5 | 412.9 | 438.5 | 385.4 | 386.0 |
Gross margin (%) | 35.7 | 39.0 | 41.8 | 40.7 | 40.1 |
EBITDA (EUR Mn) | 58.5 | 126.5 | 142.5 | 120.8 | 125.1 |
EBITDA margin (%) | 7.3 | 12.0 | 13.6 | 12.8 | 13.0 |
Net income attributable (EUR Mn) | 8.9 | 75.2 | 80.2 | 63.0 | 71.6 |
Net margin (%) | 1.1 | 7.1 | 7.6 | 6.7 | 7.4 |
Gross dividend per share (EUR) | 0.40 | 0.44 | 0.48 | 0.51 | 0.55 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Margin Analysis (%) (FY2023–FY2025)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
EBIT reported (EUR Mn) | 91.3 | 66.0 | 76.2 |
Adjusted EBIT (EUR Mn) | 102.1 | 77.1 | 79.0 |
Adjusted EBIT margin (%) | 9.7 | 8.1 | 8.2 |
Restructuring & impairment (EUR Mn) | 10.8 | 11.1 | 2.8 |
D&A (EUR Mn, derived = EBITDA − adj. EBIT) | 40.4 | 43.7 | 46.1 |
Income tax (EUR Mn) | 17.3 | 12.8 | 14.5 |
Effective tax rate (%) | 18 | 18 | 18 |
Pre-tax income (EUR Mn, derived = NI + tax) | 97.5 | 75.8 | 86.1 |
EPS basic (EUR) | 0.89 | 0.71 | 0.85 |
EPS diluted (EUR) | 0.88 | 0.70 | 0.85 |
Key Financials
| Opex line (EUR Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
R&D expense (EUR Mn) | 132.3 | 130.9 | 121.5 |
Sales & marketing (EUR Mn) | 145.9 | 138.1 | 133.7 |
General & administration (EUR Mn) | 59.9 | 56.5 | 57.0 |
Total indirect expenses (EUR Mn) | 338.1 | 325.5 | 312.3 |
Other operating income (EUR Mn) | 1.7 | 17.1 | 5.2 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (EUR Mn, aggregator) | 1,104 | 1,147 | 1,159 | 1,229 | 1,100 |
Total equity incl. minorities (EUR Mn, aggregator) | 735 | 779 | 811 | 795 | 715 |
Cash & equivalents (EUR Mn, aggregator) | 352 | 306 | 286 | 362 | 260 |
Trade receivables (EUR Mn) | 157.0 | 194.6 | 208.6 | 201.5 | 202.9 |
Inventory (EUR Mn) | 175.5 | 245.7 | 231.5 | 208.7 | 206.4 |
Trade payables (EUR Mn) | 114.0 | 121.9 | 89.4 | 98.9 | 112.8 |
Net working capital (EUR Mn) | 46.8 | 150.4 | 174.8 | 111.5 | 126.5 |
Key Financials (FY2021–1H2026)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | 1H2026 |
|---|---|---|---|---|---|---|
Net financial cash / (debt) (EUR Mn) | — | 264 | 241.1 | 259.0 | 186.2 | -32.6 |
Goodwill (EUR Mn) | — | — | 105.6 | 105.6 | 105.6 | n/a (rises with VerVent; PPA not disclosed) |
Implied gross financial debt incl. leases (EUR Mn, derived = cash − net cash) | — | 42 | 45 | 103 | 74 | — |
NWC as % of sales | 5.8 | 14.2 | 16.6 | 11.8 | 13.1 | — |
Cash Flow and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross operating free cash flow (EUR Mn) | 50.5 | 127.0 | 138.3 | 101.5 | 125.1 |
Change in net working capital (EUR Mn) | 55.5 | -95.5 | -37.5 | 59.8 | -14.8 |
Net operating free cash flow (EUR Mn) | 106.1 | 31.5 | 100.8 | 161.3 | 110.2 |
Income taxes paid (EUR Mn) | -8.4 | -6.0 | -13.3 | -26.3 | -19.4 |
FCF from operating activities (EUR Mn) | 96.6 | 26.3 | 92.2 | 140.3 | 95.5 |
Capex (EUR Mn) | 18.8 | 21.2 | 54.4 | 42.6 | 38.5 |
Free cash flow (EUR Mn) | 78.0 | 13.1 | 38.0 | 110.3 | 57.2 |
FCF margin (%) | 9.7 | 1.2 | 3.6 | 11.7 | 5.9 |
Dividends & Capital Returns
| Metric | FY2024 | FY2025 | 1H2026 |
|---|---|---|---|
Dividends paid (EUR Mn) | ~44.5 (statutory) | 44.2 | paid (amount not disclosed in PR) |
Share buybacks — cash (EUR Mn) | n/a (programme to replenish option pool) | 79.1 | ~9 (tail of EUR 30M programme; derived) |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%, NI / year-end equity, derived) | 1.2 | 9.7 | 9.9 | 7.9 | 10.0 |
ROA (%, NI / total assets, derived) | 0.8 | 6.6 | 6.9 | 5.1 | 6.5 |
Asset turnover (x, sales / total assets, derived) | 0.73 | 0.92 | 0.91 | 0.77 | 0.88 |
DSO (days) | 56 | 54 | 63 | 63 | 65 |
DPO (days) | 80 | 68 | 50 | 61 | 70 |
Inventory turns (x) | 2.4 | 2.1 | 2.1 | 2.1 | 2.2 |
Cash conversion cycle (days, derived = DSO + 365/turns − DPO) | 128 | 160 | 187 | 176 | 161 |
Returns & Leverage Ratios (%) and Financial Ratios (x) (FY2023–FY2025)
| Ratio | FY2023 | FY2024 | FY2025 | Comment |
|---|---|---|---|---|
ROCE (company-reported, %) | 17 | 14 | 14 | 1H25 LTM: 16% |
Current ratio (x, aggregator) | 3.11 | 2.59 | — | FY21 2.85; FY22 2.84 |
Net debt / EBITDA (x) | -1.7 | -2.1 | -1.5 | Net cash; 1H26 net debt ≈0.3x LTM EBITDA (derived, LTM EBITDA ≈103M) |
Debt / equity (x, derived gross debt incl. leases) | 0.06 | 0.13 | 0.10 | Minimal financial leverage |
Interest coverage | n/m | n/m | n/m | Net interest income positive (EUR +4.7M / +5.3M / +4.7M) |
Region share of sales (%)
| Region share of sales (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Americas share (%) | 37 | 41 | 40 | 47 | 45 |
EMEA share (%) | 38 | 38 | 40 | 32 | 35 |
APAC share (%) | 25 | 21 | 20 | 21 | 20 |
Region sales (EUR Mn, derived)
| Region sales (EUR Mn, derived) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Americas sales (EUR Mn) | 297.6 | 433.9 | 420.0 | 444.9 | 433.7 |
EMEA sales (EUR Mn) | 305.6 | 402.2 | 420.0 | 302.9 | 337.3 |
APAC sales (EUR Mn) | 201.1 | 222.2 | 210.0 | 198.8 | 192.8 |
Region share of orders (%)
| Region share of orders (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Americas orders share (%) | 37 | 43 | 46 | 52 | 45 |
EMEA orders share (%) | 37 | 37 | 36 | 30 | 36 |
APAC orders share (%) | 26 | 20 | 18 | 18 | 19 |
Division Overview — Entertainment
| Division | Americas | EMEA | APAC |
|---|---|---|---|
Entertainment (FY25) | Flat (tariffs, FX); largest Cinema region; HDR roll-out; 1H26 Cinema growth | Main growth engine (both BUs; Middle East theme parks); 1H26 IE weak in Middle East | Solid (India, Japan); China cinema weak in 1H26 on local content |
Enterprise (FY25) | ME stable; CR slow (tariffs, government delays) | ME stable; CR strong growth (software); Middle East soft (LED price war) | ME decline (competition); CR strong (SE Asia, India infrastructure) |
Healthcare (FY25) | Weak (tariffs, lower government spending, US shutdown Oct–Nov 2025, FX) | Mammography/radiology double-digit growth | Single-digit growth in diagnostic; weaker overall |
Share Price & Returns
| Reference point | Price (EUR) | Change to EUR 7.16 (16 Oct 2026) | Source |
|---|---|---|---|
52-week high (to mid-Oct 2026) | 13.17 | −46% | ad-hoc-news |
52-week low | 6.85 | +5% | ad-hoc-news |
Start of 2026 (implied by −40% YTD) | ~11.9 | ~−40% YTD | MarketScreener (−39.9% YTD on 9 Oct 2026) |
Apr 2022 optional-dividend issue price | 19.60 | −63% | Barco PR, 28 Apr 2022 |
Apr 2021 optional-dividend issue price (~5-year reference) | 18.79 | −62% | Barco PR, 29 Apr 2021 |
Valuation Multiples
| Multiple | Barco | Basis |
|---|---|---|
P/E (FY25 EPS EUR 0.85) | 8.4x | Derived |
P/E (TTM EPS ~EUR 0.53) | ~13.5x | Investing.com TTM EPS; ad-hoc-news cites 13.45–13.83x |
EV/EBITDA (FY25 EBITDA EUR 125.1M) | 5.3x | Derived |
EV/EBITDA (LTM to 1H26, EBITDA ~EUR 103M) | ~6.4x | Derived (125.1 − 48.0 + 26.1) |
EV/Sales (FY25) | 0.68x | Derived |
P/B (FY25 equity ~EUR 715M, aggregator) | ~0.87x | Derived |
Dividend yield (EUR 0.55 FY25 DPS) | ~7.7% | Derived (a third-party figure of 0.08% appears to be a formatting error) |
Analyst Ratings & Targets
| Broker / source | Date | View / target |
|---|---|---|
KBC Securities (Guy Sips) | Oct 2025 (post-CMD) | Hold, TP EUR 14 |
KBC Securities | 29 Sep 2026 | TP cut to EUR 9.70; execution in 4Q26 seen as crucial; book-to-bill expected >1.0 in 2026 |
Test-Aankoop/Test-Achats Invest | Feb 2026 | Buy (dividend +7.8% to EUR 0.55) |
Test-Aankoop/Test-Achats Invest | Apr 2026 | Downgraded (no longer Buy); EPS estimates EUR 0.94 (2026) and EUR 1.00 (2027) |
Coverage | — | ~10 analysts (Simply Wall St); formal consensus not publicly accessible |
Dividend metric
| Dividend metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross DPS (EUR) | 0.40 | 0.44 | 0.48 | 0.51 | 0.55 |
DPS YoY growth (%) | 5.8 | 10.0 | 9.1 | 6.3 | 7.8 |
Capital Markets
| Item | Status |
|---|---|
Moody's / S&P / Fitch ratings | None identified (Barco is unrated) |
Bonds outstanding | None identified |
Debt maturity profile | Not publicly disclosed in sources reviewed; gross debt mainly leases (~EUR 74M implied at FY25, derived) |
Net financial position | Net debt EUR 32.6M (30 Jun 2026) vs net cash EUR 186.2M (31 Dec 2025) |
Analyst Conclusions
Management guidance
FY2026 (15 Jul 2026): Sales above FY2025 (EUR 963.8M), including VerVent (consolidated from May; about EUR 70M+ of annualized contribution for eight months, derived from ~EUR 110M per year). EBITDA margin 11–12%, against 13.0% in FY25. This implies 2H26 EBITDA of roughly EUR 85–95M at a 15–17% 2H margin (derived), a demanding back-end load.
2028: ~EUR 1.1bn revenue, 15% EBITDA margin, 15% recurring revenue (reaffirmed including VerVent).
Consensus expectations
No formal consensus is publicly accessible. KBC sees FY26 targets still achievable if the year-end materializes, and book-to-bill above 1.0. Test-Aankoop forecasts EPS of EUR 0.94 (2026) and EUR 1.00 (2027). Both are set against 1H26 EPS of EUR −0.06, which implies a very strong H2.
Bull case
-
The order book is rebuilding. It reached EUR 568.3M at end-1H26 (vs EUR 492.8M at FY25), with a positive book-to-bill throughout 1H26 and Americas orders +8%. The pattern supports a classic Barco 2H skew (2H25 EBITDA margin was 15.1%).
-
HDR by Barco plus CaaS convert Cinema into an annuity. EUR 89M TCV signed in FY25, 45+ titles in 2026 and major exhibitor commitments (Vue, Regal, Cineplex) should raise recurring revenue toward 15% and make margins more stable.
-
Valuation already discounts failure. At ~5–6x EV/EBITDA, ~0.9x book and a ~7.7% dividend yield, with a family anchor and a 6% share-count reduction, modest recovery to FY25 EBITDA levels could re-rate the shares substantially.
Bear case
-
Structural decline in Enterprise. Enterprise EBITDA has halved since FY22, BYOD sell-out is falling double-digit, and ClickShare Hub is a late entry against entrenched room-system players.
-
Earnings quality and cash conversion are deteriorating. 1H26 brought a net loss, EUR −36.7M FCF, an inventory build and a swing to net debt. The FY26 margin guide (11–12%) is already about 1–2 pts below FY25, and the 2028 15% target looks increasingly aspirational.
-
Capital allocation and macro risk. VerVent dilutes margins and moves Barco into cyclical consumer audio at ~1.2x sales just as the core business weakened. US tariffs and FX (≈45% Americas exposure) remain unresolved.
Catalysts and monitorables (next 12 months)
| Date / period | Catalyst | What to watch |
|---|---|---|
| 20 Oct 2026 | 3Q26 trading update | Order intake vs 3Q25 (EUR 222.1M); sales trajectory vs 2H guide; reiteration of the 11–12% margin |
| 4Q26 | Cinema bulk orders; HDR installs | Number of HDR systems (vs ~100 pipeline) |
| Feb 2027 | FY26 results | EBITDA margin delivery; FCF and inventory unwind; net debt; dividend decision (risk of a flat or lower DPS) |
| 2026–27 | VerVent integration | Consumer Experience margin; synergy disclosure |
| 2026–27 | ClickShare Hub ramp | Bundles, MTR attach rates, Meeting Experience stabilization |
| 2026–27 | Healthcare | New surgical contracts; digital pathology growth; Suzhou cost competitiveness |
| Ongoing | Trade policy / FX | US tariff regime; EUR/USD |
| Ongoing | Capital allocation | New buyback (unlikely near term) vs deleveraging; any further M&A |
Analyst verdict
Barco enters late 2026 as a high-quality franchise trapped in a low-quality earnings cycle. The core assets are genuinely differentiated. It leads laser cinema and premium projection, holds a patented PLF technology in HDR by Barco Lightsteering, owns a defensible diagnostic-display business, and has rebuilt Control Rooms around secure software. Its management has shown real cost discipline: opex fell more than 5% in FY25 and the EBITDA margin reached 13.0% despite tariffs and currency.
Yet the group has not grown its topline since FY22. FY25 sales of EUR 963.8M remain about 9% below the 2022 peak. Enterprise's profit pool has halved as the agnostic meeting-room category erodes. Healthcare is range-bound and exposed to US policy.
The first half of 2026 exposed how thin the cushion is. EBITDA margin fell to 6.2%, the half produced a net loss and negative free cash flow, and net cash of EUR 186M turned into net debt within six months. Part of that swing reflects the VerVent purchase, and part reflects working capital going the wrong way.
The investment debate therefore rests almost entirely on execution in the second half of 2026 and on whether recurring Cinema revenue can scale fast enough to offset cyclical hardware.
Valuation offers substantial protection. EV/EBITDA is roughly 5–6x on FY25 earnings, the dividend yield is near 8% and the shares trade below book value. That pricing implies the market believes neither the 11–12% FY26 margin nor the 2028 targets of EUR 1.1bn revenue and a 15% margin.
Our synthesis is cautiously constructive on asset value but neutral on near-term fundamentals. A credible 3Q26 order print and a 2H26 margin above 15% would validate a re-rating toward the KBC target of about EUR 9.70. Another guidance slip would raise questions about the dividend, about the VerVent rationale and, ultimately, about strategic options for a family-anchored company trading at a deep discount. The 20 October trading update is the near-term swing factor.
End of dossier. Figures reflect information available up to 19 October 2026 and exclude the 3Q26 trading update scheduled for 20 October 2026. "Derived" values are arithmetic on disclosed figures; "aggregator" values should be reconciled with Barco's audited Integrated Report before use.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Term ends (AGM) | Independent | Committees | Background (where disclosed/known) |
|---|---|---|---|---|---|
Charles Beauduin | Chairman | 2,027 | No (reference shareholder, Titan Baratto) | Technology (Chair) | Long-standing Barco director; former co-CEO during the 2021–23 transition |
An Steegen | CEO & Director | 2,027 | No (executive) | Technology | Engineer/semiconductor background (imec, Umicore); Barco CEO |
Frank Donck | Director | 2,027 | Yes | Remuneration & Nomination (Chair), Audit | Belgian investor/director (3D NV-linked) |
Adisys Corporation, represented by Ashok K. Jain | Director | 2,027 | Yes | Technology, Remuneration & Nomination | Technology/semiconductor background |
Hilde Laga | Director | 2,028 | No (per board listing) | Audit, Remuneration & Nomination | Belgian lawyer/director |
Lieve Creten | Director | 2,028 | Yes | Audit (Chair), Remuneration & Nomination | Finance/audit background |
Lord James Sassoon | Director | 2,030 | Yes | Audit, Remuneration & Nomination | UK financier/former Treasury minister |
Kurt Verheggen | Company Secretary (General Counsel) | — | — | — | Group General Counsel |
Executive Leadership Team
| Name | Role | Notes |
|---|---|---|
An Steegen | Chief Executive Officer | Led the 2026 simplification and the VerVent deal |
Ann Desender | CFO (listed) | Barco since 2008; CFO since Sept 2016; MSc Applied Economic Sciences (Ghent), AMP (IESE); ex-Unilin, Arthur Andersen, Deloitte. The July 2026 release says CFO and CDIO roles were combined. Who holds the combined role was not confirmed in sources reviewed |
Ta Loong Gan | EVP & General Manager (APAC) | Per SI Asia interview |
Jan van Houtte | EVP Meeting Experience | Per Barco Yealink PR (2024) |
Kurt Verheggen | General Counsel & Company Secretary | Led Yealink litigation |
John Zhao | EVP Healthcare (all Healthcare activities since Jul 2026) | Unified Healthcare leadership |
Willem Fransoo | Director Investor Relations (not on executive committee) | IR contact |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Sept 2016 | Ann Desender succeeds Carl Peeters as CFO | Peeters left for Greenyard |
| 2016 | Jan De Witte succeeds Eric Van Zele as CEO | "Focus to Perform" |
Nov 2021 | Leadership update; An Steegen joins leadership (co-led with Charles Beauduin) | Transition to new CEO |
2023–24 | An Steegen sole CEO; Beauduin chairs | FY24 PR CEO quote |
FY2025 | Surgical brought under common leadership with Diagnostic Imaging | Performance issues in surgical |
15 Jul 2026 | More compact senior leadership and overhead structure; Healthcare unified under John Zhao; CFO and CDIO responsibilities combined | Cost actions after a weak 1H26 |
Major Shareholders
| Holder | Shares | % of 87.34M | Basis / date |
|---|---|---|---|
Titan Baratto NV (Beauduin family) | ~23.47M | ~26.9% | Aggregator (Simply Wall St) holding count; 19.84% in Jun 2021 per Barco PR. Increased since via scrip and buyback-driven share-count reduction |
3D Investors (3D NV) | ~5.27M | ~6.0% | Aggregator; 4.23% in Jun 2021 |
Alantra EQMC Asset Management | ~2.76M | ~3.2% | Aggregator |
BNP Paribas Asset Management (Holding + Europe) | ~3.77M | ~4.3% | Aggregator (two entities combined) |
The Vanguard Group | ~2.41M | ~2.8% | Aggregator |
BlackRock | ~1.31M | ~1.5% | Aggregator |
Dimensional Fund Advisors | ~0.95M | ~1.1% | Aggregator |
Value Square NV | ~0.27M | ~0.3% | Aggregator |
KBC Asset Management | ~0.26M | ~0.3% | Aggregator |
BNY Asset Management | ~0.26M | ~0.3% | Aggregator |
Competitive Landscape
Competitors by Segment
| Segment | Key competitors | Barco's relative position |
|---|---|---|
Cinema projection | Christie Digital (Ushio), Sharp NEC Display Solutions, Appotronics/ALPD (China), Sony (legacy base) | Global leader in DCI laser cinema projection (company claim of leadership) |
Premium large format (PLF) | IMAX, Dolby Cinema, Cinionic-era Barco Laser PLF, exhibitor-own PLFs | HDR by Barco is a challenger brand to IMAX/Dolby, differentiated by image quality and flexible business models |
Immersive / high-brightness projection | Christie, Panasonic Connect, Epson, Sony, Sharp NEC | Leader in 3-DLP high-end; gaining share in 1-DLP mid-segment (I600) |
Image processing (live events) | Analog Way, disguise, Brompton (LED processing), Novastar | Encore 3 / Event Master strong in high-end live events |
Meeting rooms (wireless BYOD / room systems) | Logitech, Neat, HP Poly, Yealink, Cisco, Crestron, Mersive (Solstice), Airtame, Kindermann | Leader in the agnostic BYOD niche, but the niche is shrinking; Hub is a late entry to the room-system market |
Control rooms (video walls / KVM) | Christie, Planar (Leyard), Mitsubishi Electric, Delta/Vivitek, Samsung, LG; KVM: Adder, IHSE, Black Box, G&D | Repositioned as software/KVM specialist; sole remaining rear-projection supplier; weaker in commoditized LED |
Diagnostic displays | EIZO, LG, JVC Kenwood, Sony, Advantech | Long-standing #1–2 in radiology/mammography displays (industry consensus; exact share not disclosed) |
Surgical / digital OR | Stryker, Karl Storz, Olympus, Steris, Getinge, Sony Medical | Niche networking/display player (Nexxis); recent contract losses |
Premium audio (new) | Bowers & Wilkins (Masimo/Harman sale history), KEF, Bang & Olufsen, Sonos (premium), Devialet, Harman (Samsung), Linn | Focal/Naim are top-tier audiophile brands of sub-scale size (~EUR 110M revenue) |
Peer Comparison FY2025
| Company | Latest FY revenue | Growth | Gross margin | EBITDA / op. margin | R&D % sales | Notes |
|---|---|---|---|---|---|---|
Barco | EUR 963.8M (FY25) | +1.8% | 40.1% | EBITDA 13.0%; adj. EBIT 8.2% | 12.6% | Verified (FY25 PR) |
Logitech International | ~USD 4.5bn (FY Mar-2025) | Low-to-mid single digit | ~43% (approx.) | Op. margin mid-teens (approx.) | ~6–7% (approx.) | — |
IMAX Corporation | ~USD 350M (FY2024) | — | — | — | — | — |
Christie Digital (Ushio) | Not publicly disclosed (subsidiary) | — | — | — | — | Main cinema/projection rival |



